Yazid Al Hamarneh
Associate Professor
Scientific Officer of Alberta SPOR SUPPORT Unit
Associate Director, Epicore Centre
Education
BSc Pharmacy, University of Jordan
PhD, Clinical Pharmacy and Pharmacy Practice, Queen’s University, Belfast
Postdoctoral Fellowship, Cardiology and Research Methods, University of Alberta
Contact Information:
Office: 3-62 Heritage Medical Research Centre
Tel: 780.492.9608
Teaching: PMCOL 403, PMCOL 408
Research: Health services research with a special focus on chronic disease (particularly cardiovascular disease and its risk factors) management in the community
Research Interests / Laboratory Techniques
Chronic disease prevention and management with special interest in cardiovascular disease and pharmacy practice. This research involves focusing on prevention, increasing awareness, improving control and management of cardiovascular disease and its risk factors as well as making the paradigm shift in pharmacy practice to focus on patient-centered care
Selected Recent Publications
Al Hamarneh YN, Ramrattan DA, Tsuyuki RT, Sullivan KW, Pan B, Simpson SH. What services do people seek when they visit a community pharmacy care clinic? Canadian Pharmacists Journal/Revue des Pharmaciens du Canada, 2026. 159(1), pp.59-69. (The winner of best oral presentation at FIP Conference 2025)
d'Entremont-Harris M, Ramsey TD, MacNabb K, Murphy A, Bishop A, Isenor JE, Kelly DV, Al Hamarneh YN, Lee M, Ferguson A, Furlotte K, Woodill L, Hatchette T, Wilby KJ. Implementation and acceptance of pharmacists' prescribing of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP). Can Pharm J (Ott). 2025 Aug 22;158(5):302-311. doi: 10.1177/17151635251355277. PMID: 40881659; PMCID: PMC12373644. (The winner of the best Canadian Pharmacist Journal 2026
Liu S, Tsuyuki RT, Graham MM, Nelson D, Semeniuk G, Al Hamarneh YN. Implementation of Pharmacist Case-Finding and Care Pathway Intervention for Vascular Prevention (PRxOACT): Protocol for a Randomized Controlled Trial. CJC Open. 2025 Mar 20;7(6):821-831. doi.org/10.1016/j.cjco.2025.03.011. PMID: 40586019; PMCID: PMC12198587. (This one is already there but it was the winner of best oral presentation at FIP 2026)
Al Hamarneh YN, Paes D, Tsuyuki RT. With great power comes great responsibility. The role of pharmacists in ensuring health equity. Can Pharm J (Ott). 2025 Sep 7;158(5):251-255. doi: 10.1177/17151635251362250. PMID: 40927222; PMCID: PMC12414980.
Aggarwal M, Dolovich L, Al Hamarneh Y, Kokorelias KM, Beall R, Upshur R. Informing a governance model for integration of community pharmacists and family physicians and nurse practitioner-led practices and teams within Ontario Health Teams: A protocol. PLoS One. 2025 Jun 17;20(6):e0325270. doi.org/10.1371/journal.pone.0325270. PMID: 40526636; PMCID: PMC12173222.
Watson KE, Schindel TJ, Meilianti S, Tsuyuki RT, Al Hamarneh YN. An international portrait of pharmacists’ professional role identities: A Q-methodology innovative study. Explor Res Clin Soc Pharm. 2025 May 26;19:100616. doi.org/10.1016/j.rcsop.2025.100616. PMID: 40510632; PMCID: PMC12162049.
Chu NY, Yushko L, Pan B, Hamarneh YNA, Watson KE, Tsuyuki RT, Smyth P. Evaluating the impact of systematic reporting of patient-reported outcome measures on depression and anxiety levels in people with multiple sclerosis: a randomized controlled trial. Mult Scler Relat Disord. 2025 Jul;99:106502. doi.org/10.1016/j.msard.2025.106502. Epub 2025 May 4. PMID: 40339265.
Liu S, Tsuyuki RT, Graham MM, Nelson D, Semeniuk G, Al Hamarneh YN. Implementation of Pharmacist Case-Finding and Care Pathway Intervention for Vascular Prevention (PRxOACT): Protocol for a Randomized Controlled Trial. CJC Open. 2025 Mar 20;7(6):821-831. doi.org/10.1016/j.cjco.2025.03.011. PMID: 40586019; PMCID: PMC12198587.
Watson KE, Chan JCH, Pan B, Al Hamarneh YN, Tsuyuki RT. Enhancing hypertension detection and control through a hypertension certification program for pharmacists: A cluster randomized trial (The RxPATH Study). Can Pharm J (Ott). 2024 May 31;157(4):190-199. doi.org/10.1177/17151635241254089. PMID: 39092087; PMCID: PMC11290583.